GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (BSP:G1SK34) » Definitions » Cyclically Adjusted PB Ratio

GSK (BSP:G1SK34) Cyclically Adjusted PB Ratio : 6.04 (As of May. 31, 2025)


View and export this data going back to 2020. Start your Free Trial

What is GSK Cyclically Adjusted PB Ratio?

As of today (2025-05-31), GSK's current share price is R$46.90. GSK's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was R$7.77. GSK's Cyclically Adjusted PB Ratio for today is 6.04.

The historical rank and industry rank for GSK's Cyclically Adjusted PB Ratio or its related term are showing as below:

BSP:G1SK34' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 5.02   Med: 8.16   Max: 12
Current: 5.83

During the past years, GSK's highest Cyclically Adjusted PB Ratio was 12.00. The lowest was 5.02. And the median was 8.16.

BSP:G1SK34's Cyclically Adjusted PB Ratio is ranked worse than
86.09% of 683 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs BSP:G1SK34: 5.83

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

GSK's adjusted book value per share data for the three months ended in Mar. 2025 was R$10.315. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is R$7.77 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


GSK Cyclically Adjusted PB Ratio Historical Data

The historical data trend for GSK's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Cyclically Adjusted PB Ratio Chart

GSK Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.29 8.76 6.76 6.28 5.29

GSK Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.25 6.33 6.15 5.29 5.66

Competitive Comparison of GSK's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, GSK's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSK's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where GSK's Cyclically Adjusted PB Ratio falls into.


;
;

GSK Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

GSK's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=46.90/7.77
=6.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, GSK's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=10.315/136.1000*136.1000
=10.315

Current CPI (Mar. 2025) = 136.1000.

GSK Quarterly Data

Book Value per Share CPI Adj_Book
201506 3.396 100.100 4.617
201509 3.362 100.200 4.567
201512 3.050 100.400 4.135
201603 1.518 100.400 2.058
201606 0.286 101.000 0.385
201609 0.060 101.500 0.080
201612 0.479 102.200 0.638
201703 0.677 102.700 0.897
201706 0.348 103.500 0.458
201709 0.553 104.300 0.722
201712 -0.030 105.000 -0.039
201803 -0.032 105.100 -0.041
201806 1.860 105.900 2.390
201809 2.444 106.600 3.120
201812 1.872 107.100 2.379
201903 2.053 107.000 2.611
201906 1.770 107.900 2.233
201909 6.015 108.400 7.552
201912 6.148 108.500 7.712
202003 7.956 108.600 9.971
202006 8.796 108.800 11.003
202009 9.958 109.200 12.411
202012 10.027 109.400 12.474
202103 11.547 109.700 14.326
202106 10.777 111.400 13.167
202109 11.115 112.400 13.459
202112 11.250 114.700 13.349
202203 10.546 116.500 12.320
202206 10.010 120.500 11.306
202209 5.345 122.300 5.948
202212 6.615 125.300 7.185
202303 7.376 126.800 7.917
202306 7.597 129.400 7.990
202309 7.916 130.100 8.281
202312 8.163 130.500 8.513
202403 8.590 131.600 8.884
202406 9.658 133.000 9.883
202409 10.059 133.500 10.255
202412 10.336 135.100 10.413
202503 10.315 136.100 10.315

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


GSK  (BSP:G1SK34) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


GSK Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of GSK's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GSK Business Description

Industry
Address
79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK Headlines

No Headlines